))
Here's the Incredible Promise of Medicine That Targets Our DNA
Archived series ("HTTP Redirect" status)
Replaced by: Foundering
When?
This feed was archived on June 19, 2017 20:11 (
Why? HTTP Redirect status. The feed permanently redirected to another series.
What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 176824592 series 1274437
Content provided by Bloomberg News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bloomberg News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Around the world, people suffer from a genetic condition called hemophilia. Even with expensive and time-consuming treatments, simple injuries for these patients hold the threat of turning into serious complications and even life-threatening events. But now, one biotech company has stumbled upon what very early trials suggest could be a "cure" -- something that, with a single intravenous drip, essentially corrects the genetic mutation that causes the disorder. This week, Bloomberg's Doni Bloomfield visits the scientists behind this treatment and a patient who has actually tried it. If it works, researchers may have pushed the door open to a whole new world of treatments that tackle these diseases at their source: our DNA.
…
continue reading
45 episodes
Share
